Cargando…

Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer

Detalles Bibliográficos
Autor principal:	Rizzo, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626325/ https://www.ncbi.nlm.nih.gov/pubmed/35989551 http://dx.doi.org/10.1111/1759-7714.14619

Ejemplares similares

Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Bao, Yongxing, et al.
Publicado: (2022)

Comments on “Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis”
por: Tsang, Yuk‐Ming, et al.
Publicado: (2022)

Comment on “bronchus perforation by EZ-Blocker(TM) endobronchial blocker during esophageal resection after neoadjuvant chemoradiation”
por: Parab, Swapnil Y
Publicado: (2019)

Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer
por: Rizzo, Alessandro
Publicado: (2023)

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
por: Li, Xiaokun, et al.
Publicado: (2022)

Excellent clinical outcomes can be achieved with neoadjuvant chemoradiation and orthotopic liver transplantation for unresectable cholangiocarcinoma: support for the need of an international transplant protocol
por: Laughlin, Brady S., et al.
Publicado: (2022)

Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis
por: Bao, Yongxing, et al.
Publicado: (2022)

Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery
por: Osong, Biche, et al.
Publicado: (2022)

Long-term survival after concurrent chemoradiation therapy for esophageal cancer with tracheal invasion
por: Cho, Joon Hyun, et al.
Publicado: (2015)

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
por: Triantafyllou, Tania, et al.
Publicado: (2020)

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
por: Warnecke-Eberz, Ute, et al.
Publicado: (2020)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery
por: Wu, Ya-hua, et al.
Publicado: (2021)

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis
por: SCHULZE, BJÖRN, et al.
Publicado: (2014)

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
por: Hu, Qiancheng, et al.
Publicado: (2019)

Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma
por: Seyedin, Steven N., et al.
Publicado: (2020)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma
por: Kandilis, Apostolos, et al.
Publicado: (2020)

Bronchus perforation by EZ-Blocker(TM) endobronchial blocker during esophageal resection after neoadjuvant chemoradiation -a case report-
por: van de Pas, Jorien M, et al.
Publicado: (2019)

A Prospective Study of Early Radiation Associated Cardiac Toxicity Following Neoadjuvant Chemoradiation for Distal Esophageal Cancer
por: Burke, Aidan M., et al.
Publicado: (2020)

Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment
por: Chou, Hsu-Huan, et al.
Publicado: (2021)

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
por: Lee, Jin Ho, et al.
Publicado: (2015)

Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer
por: NAKAMURA, RIEKO, et al.
Publicado: (2016)

Handgrip Strength Is Associated With Treatment Modifications During Neoadjuvant Chemoradiation in Patients With Esophageal Cancer
por: Lakenman, Patty, et al.
Publicado: (2017)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
por: Macedo‐Silva, Catarina, et al.
Publicado: (2023)

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Treatment for Resectable Esophago-Gastric Cancer: A Systematic Review and Meta-Analysis
por: Meng, Xiangyu, et al.
Publicado: (2019)

Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
por: Riou, Olivier, et al.
Publicado: (2023)

Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy
por: Zhang, Chi, et al.
Publicado: (2015)

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
por: van Heijl, M, et al.
Publicado: (2008)

Comment on “Prognosis of Patients With Esophageal Carcinoma Following Routine Thoracic Duct Resection: A Propensity-Matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan”
por: Udagawa, Harushi
Publicado: (2023)

Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels
por: Takahashi, Jun, et al.
Publicado: (2018)

Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
por: Dings, Mark P.G., et al.
Publicado: (2022)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

Molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation
por: Ajani, J A
Publicado: (2008)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas
por: Soeratram, Tanya TD, et al.
Publicado: (2021)

Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma
por: FUJIWARA, YOSHINORI, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4t5qvba8mtgub74dadt5219qlp